Cargando…
Targeting Wnt pathway in mantle cell lymphoma-initiating cells
BACKGROUND: Mantle cell lymphoma (MCL) is an aggressive and incurable form of non-Hodgkin’s lymphoma. Despite initial intense chemotherapy, up to 50 % of cases of MCL relapse often in a chemoresistant form. We hypothesized that the recently identified MCL-initiating cells (MCL-ICs) are the main reas...
Autores principales: | Mathur, Rohit, Sehgal, Lalit, Braun, Frank K., Berkova, Zuzana, Romaguerra, Jorge, Wang, Michael, Rodriguez, M. Alma, Fayad, Luis, Neelapu, Sattva S., Samaniego, Felipe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460883/ https://www.ncbi.nlm.nih.gov/pubmed/26048374 http://dx.doi.org/10.1186/s13045-015-0161-1 |
Ejemplares similares
-
Inhibition of Methyltransferases Accelerates Degradation of cFLIP and Sensitizes B-Cell Lymphoma Cells to TRAIL-Induced Apoptosis
por: Braun, Frank K., et al.
Publicado: (2015) -
LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
por: Wang, Xin, et al.
Publicado: (2016) -
Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironment
por: Zhang, Han, et al.
Publicado: (2016) -
Nuclear Translocation of B-Cell-Specific Transcription Factor, BACH2, Modulates ROS Mediated Cytotoxic Responses in Mantle Cell Lymphoma
por: Chen, Zheng, et al.
Publicado: (2013) -
CD74 interferes with the expression of fas receptor on the surface of lymphoma cells
por: Berkova, Zuzana, et al.
Publicado: (2014)